Access the full text.
Sign up today, get DeepDyve free for 14 days.
MA Hlatky, P Greenland, DK Arnett (2009)
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association [published correction appears in Circulation. 2009 Jun 30;119(25):e606], 119
M. Budoff, T. Mayrhofer, M. Ferencik, D. Bittner, Kerry Lee, Michael Lu, Adrian Coles, James Jang, M. Krishnam, P. Douglas, U. Hoffmann (2017)
Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)Circulation, 136
Matthew Ostrom, A. Gopal, N. Ahmadi, K. Nasir, Eric Yang, I. Kakadiaris, F. Flores, S. Mao, M. Budoff (2008)
Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography.Journal of the American College of Cardiology, 52 16
D. Pryor, L. Shaw, C. McCants, Kerry Lee, D. Mark, F. Harrell, L. Muhlbaier, R. Califf (1993)
Value of the History and Physical in Identifying Patients at Increased Risk for Coronary Artery DiseaseAnnals of Internal Medicine, 118
M. Ferencik, T. Mayrhofer, D. Bittner, H. Emami, S. Puchner, Michael Lu, N. Meyersohn, A. Ivanov, Elizabeth Adami, M. Patel, D. Mark, J. Udelson, Kerry Lee, P. Douglas, U. Hoffmann (2018)
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical TrialJAMA Cardiology, 3
M. Hlatky, P. Greenland, D. Arnett, C. Ballantyne, M. Criqui, M. Elkind, A. Go, F. Harrell, B. Howard, V. Howard, P. Hsue, C. Kramer, J. Mcconnell, S. Normand, Christopher O'Donnell, Sidney Smith, P. Wilson (2009)
Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart AssociationCirculation, 119
U. Hoffmann, M. Ferencik, J. Udelson, M. Picard, Q. Truong, M. Patel, Megan Huang, M. Pencina, D. Mark, J. Heitner, C. Fordyce, P. Pellikka, J. Tardif, M. Budoff, G. Nahhas, B. Chow, A. Kosinski, Kerry Lee, P. Douglas (2017)
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)Circulation, 135
P. Douglas, U. Hoffmann, M. Patel, D. Mark, H. Al-Khalidi, Brendan Cavanaugh, J. Cole, R. Dolor, C. Fordyce, Megan Huang, M. Khan, A. Kosinski, M. Krucoff, V. Malhotra, M. Picard, J. Udelson, E. Velazquez, E. Yow, L. Cooper, Kerry Lee (2015)
Outcomes of anatomical versus functional testing for coronary artery disease.The New England journal of medicine, 372 14
J. Muhlestein, D. Lappé, J. Lima, B. Rosen, H. May, S. Knight, D. Bluemke, Steven Towner, V. Le, T. Bair, A. Vavere, Jeffrey Anderson (2014)
Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.JAMA, 312 21
Risk Stratification of Patients With Chest Pain and High-Risk Plaque Original Investigation Research Invited Commentary High-Risk Coronary Atherosclerotic Plaque Assessment by Coronary Computed Tomography Angiography— Should We Use It? Raymond J. Gibbons, MD Coronary computed tomography angiography (CTA) has an tions and correctly includes stroke as an end point. The increasing role in the diagnostic and prognostic assessment of PROMISE trial included symptomatic patients with SIHD; patients with stable ischemic heart disease (SIHD). The stroke was not an end point. A more inclusive analysis would PROMISE trial has tested the have relied on historical variables of symptomatic patients, hypothesis that coronary CTA which would have included eliciting histories of peripheral vas- Related article page 144 anatomic assessment of pa- cular disease, cerebrovascular disease, and more details re- tients with SIHD would re- garding symptoms (eg, the presence of chest pain, dyspnea, duce cardiac events compared with conventional stress test- and typical angina, or not). These important variables are in- ing, but it has not found an advantage for a coronary CTA cluded in the Supplement of the study by Ferencik et al, but strategy. it is not clear whether they were ever considered in the analy- The PROMISE (Prospective
JAMA Cardiology – American Medical Association
Published: Feb 10, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.